药食同源杂志2025，Vol.1Issue(4)：1-8,8.
药食同源发酵中药产业发展现状、问题与对策
Current status,challenges,and countermeasures for developing the food-medicine homologous fermented Chinese medicines industry
摘要
Abstract
The food-medicine homologous fermented Chinese medicines,as the product of the integration of Chinese medicine and modern fermentation technology,demonstrates advantages in component transformation,efficacy enhancement,and safety improvement.Its application scope is gradually expanding.This study aspects such as fermentation processes and technologies,efficacy and mechanisms of action,industrial and market development,and laws,regulations,and policies.It reviews the current state of development in this field and identifies issues including weak foundational research,imprecise process control,delayed transformation of research outcomes,limited industrial scale,prominent product homogeneity,insufficient market cultivation,and an incomplete regulatory system.To promote industrial development,it is essential to strengthen technological innovation and microbial strain optimization,establish a systematic research framework for components and safety,advance industry-academia-research collaboration,and build a complete chain from pilot-scale testing to industrialization.Meanwhile,market education and brand building should be reinforced,and regulatory and standard systems should be improved to establish a quality supervision system covering the entire industry chain.关键词
药食同源/发酵中药/研究现状/产业发展/法规标准Key words
food-medicine homology/fermented Chinese medicines/research status/industrial development/regulations and standards分类
医药卫生引用本文复制引用
郭小舟,刘昱辛,吴越,刘嘉熙,耿燕,窦志英,谢雪姣..药食同源发酵中药产业发展现状、问题与对策[J].药食同源杂志,2025,1(4):1-8,8.基金项目
国家自然科学基金项目(81603600) （81603600）
湖南省自然科学基金项目(2025JJ90023) （2025JJ90023）
湖南省教育厅重点项目(23A0302) （23A0302）
湖南省卫生健康委基金项目(D202303018265) （D202303018265）
湖南省中医药科研基金项目(A2023035) （A2023035）
湖南中医药大学研究生创新课题项目(2024CX103). （2024CX103）
